EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions

Bess M Kew iD, Matthew P Doogue iD, Richard McNeill iD, Mei Zhang iD, Julia J Rucklidge iD, Christopher M Frampton iD, Roger T Mulder, Ben Beaglehole iD

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Bess M Kew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Micronutrients, Cytochrome P-450 Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Calgary Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Daily broad‐spectrum micronutrients are being used by the general public and formulations are receiving research interest in mental health settings. Despite concerns about combining medicines and broad‐spectrum micronutrients in mental health care, there have not been any formal evaluations of potential interactions. Our objective was to evaluate a broad‐spectrum micronutrient formula as a potential precipitant of pharmacokinetic drug–drug interactions through inhibition or induction of cytochrome P450 (CYP) enzymes.

Methods

This was a single‐centre pharmacokinetic study. Twelve healthy participants received broad‐spectrum micronutrients for 14 days (Days 1–14). Participants were administered a ‘cocktail’ of selective CYP probes midazolam 2 mg (CYP3A), dextromethorphan 30 mg (CYP2D6), losartan 25 mg (CYP2C9), omeprazole 20 mg (CYP2CI9) and caffeine 100 mg (CYP1A2) on Day 0 and Day 14, before taking and while taking broad‐spectrum micronutrients. Plasma drug concentrations were measured at baseline and for 8 h following cocktail administration. AUC, C max and T max were compared before and after broad spectrum micronutrient administration using paired t­ tests.

Results

Pre‐ and post‐micronutrient geometric means (SD) for AUC 0‐8h (μg*h/L) were: midazolam 25 (13) and 26 (14), P = 0.60; dextromethorphan 25 (99) and 19 (110), P = 0.46; losartan 219 (105) and 205 (76), P = 0.20; omeprazole 474 (394) and 402 (342), P = 016; and caffeine 13 800 (5400) and 12 800 (3500), P = 0.79. There were no statistically significant changes in geometric means of probe C max , or T max for any of the study drugs.

Conclusions

Broad‐spectrum micronutrients are unlikely to be a major precipitant of pharmacokinetic drug–drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicronutrientsCytochrome P-450 Enzyme InhibitorsHumansMaleAdultDrug InteractionsMidazolamFemaleYoung AdultOmeprazoleLosartanDextromethorphanCaffeineArea Under CurveHealthy VolunteersCytochrome P-450 Enzyme SystemMiddle Aged

Stichwörter der Autor:innen

cytochromes P450interactionsmental healthmicronutrientspharmacokinetic

Substanzen

MidazolamMicronutrientsOmeprazoleLosartanDextromethorphanCaffeineCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
  • Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Department of Toxicology, Canterbury Health Laboratories, Christchurch, New Zealand.
  • School of Psychology, Speech, and Hearing, University of Canterbury, Christchurch, New Zealand.

ORCID-Profile: Bess M Kew, Matthew P Doogue, Richard McNeill, Mei Zhang, Julia J Rucklidge, Christopher M Frampton, Ben Beaglehole

Förderung

  • Calgary Foundation

Zitieren

APA

Kew, B. M., Doogue, M. P., McNeill, R., Zhang, M., Rucklidge, J. J., Frampton, C. M., Mulder, R. T., & Beaglehole, B. (2025). Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70014

Vancouver

Kew BM, Doogue MP, McNeill R, Zhang M, Rucklidge JJ, Frampton CM, et al. Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70014

BibTeX
@article{Kew2025,
  author = {Kew, Bess M and Doogue, Matthew P and McNeill, Richard and Zhang, Mei and Rucklidge, Julia J and Frampton, Christopher M and Mulder, Roger T and Beaglehole, Ben},
  title = {Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70014}
}
Kostenlos starten →